Pharmaceutics MDPI

03/06/2026

We are honored to welcome Dr. Francois Dufrasne as a Scientific Committee Member for the 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics (ECMC-P 2026)!

Join us in shaping the future of medicinal chemistry and pharmaceutics!

📅1-30 November 2026 | Online
📜More details: https://brnw.ch/21x32Uu

🔗 Submit your abstract today: https://brnw.ch/21x32Uw
👉 Register for FREE here: https://brnw.ch/21x32Uv

Scholars, researchers, and students—don’t miss this opportunity to present your work on an international stage.

03/06/2026

🚀 Highly Cited Paper Alert!

📄 Coumarins in Anticancer Therapy: Mechanisms of Action, Potential Applications and Research Perspectives 💊
👨‍🔬 Kubrak et al.
📈 Citation: 27 💥

Read more at:

Coumarins are natural organic compounds widely found in plants that show promising anticancer properties. This article reviews the current research on the mechanisms of action of coumarins in cancer therapy, including the induction of apoptosis, inhibition of tumor cell proliferation, modulation of ...

02/06/2026

🔥 Hot Off the Press!

📄 Emerging Non-Conventional Approaches in mRNA-LNP Formulation for Therapeutic Applications 💊
👩‍🔬 Zhang et al.

🔗

Lipid nanoparticles (LNPs) have become the cornerstone of nucleic acid delivery platforms, particularly in RNA-based vaccines and therapeutics. However, the conventional methods of LNP production, which are primarily reliant on microfluidic mixing of aqueous and organic solvent phases, pose limitati...

02/06/2026

The Special Issue has been extended!

We invite you to contribute to the Special Issue entitled "New Insights into Nanomaterials for Cancer Therapy and Drug Delivery."
Guest Editors: Dr. Giordano Perini and Dr. Antonio Minopoli

3️⃣ papers have been published in the Special Issue, welcome to read at: https://brnw.ch/21x32fo

02/06/2026

⭐ New Editor's Choice Article in Pharmaceutics MDPI!

📖 Nasal Residence Depending on the Administered Dosage Form: Impact of Formulation Type on the In Vivo Nasal Retention Time of Drugs in Rats 💊

💡 Curious about the results? Read the full paper here:
🔗

Background/Objectives: The precise control of drug absorption through the nasal mucosa following intranasal administration can be achieved through optimal formulation development that considers the nasal retention properties of the administered dosage form. This study aimed to quantitatively elucida...

02/06/2026

📣 Exciting news! Special Issue Reprint Book is Out Now: "Local Drug Delivery System"!

Guest Editor: Dr. Silvia Tampucci and Dr. Daniela Monti

Download for Free or Order Online via MDPI Books:
https://brnw.ch/21x317O

02/06/2026

🚀 Highly Cited Paper Alert!

📄 Transforming Pharmacogenomics and CRISPR Gene Editing with the Power of Artificial Intelligence for Precision Medicine 💊
👨‍🔬 Srivastav et al.
📈 Citation: 26 💥

Read more at:

Background: Advancements in pharmacogenomics, artificial intelligence (AI), and CRISPR gene-editing technology are revolutionizing precision medicine by enabling highly individualized therapeutic strategies. Artificial intelligence-driven computational techniques improve biomarker discovery and drug...

01/06/2026

🔥 Hot Off the Press!

📄 Mn(II)-Tagged DOTA-Modified Sugar-Based Biopolymers as Gadolinium-Free Contrast Agents for Magnetic Resonance Imaging 💊
👩‍🔬 Pashkunova-Martic et al.

Main findings:
– Mn(II)-chelated sugar-based biopolymers were successfully synthesized and showed strong T1 MRI contrast performance
– Chitosan-DOTA-Mn(II) offered the best overall balance of relaxivity, stability, injectability, cell tolerance, and in vivo vascular/liver MRI enhancement

Implications:
– The prepared Mn-based macromolecular probes provide a promising gadolinium-free alternative for MRI contrast enhancement
– Our results support further optimization of sugar-based polymeric Mn(II) systems toward safer, more sustainable, and potentially translatable MRI contrast agents

🔗

Background: Paramagnetic manganese (Mn(II)) has emerged as a promising alternative to gadolinium-based contrast agents (GBCAs) due to its favorable magnetic properties. Despite extensive research, no Mn-based agent has yet achieved clinical translation. Because free Mn(II) is toxic, macromolecular c...

01/06/2026

The Special Issue has been extended!

We invite you to contribute to the Special Issue entitled "Nano-Drug Delivery Systems: Tackling Cancer Metabolism and Drug Resistance".
Guest Editor: Dr. Odília Queirós

Welcome to read at: https://brnw.ch/21x30u5

01/06/2026

📢 Check out our new from Novelli et al.

📰 Astaxanthin Delivery Across Administration Routes: Recent Advances to Improve Stability and Bioavailability 💊

Full text 👉 https://brnw.ch/21x2ZUM

Read more papers in Volume 18 - Issue 5 👇
https://brnw.ch/21x2ZUL